Marcin Pajkowski

TL;DR: The study validated the efficacy of proposed clinical FH criteria for the disease diagnosis in Poland and proposed that in the healthcare systems with limited genetic testing resources individuals younger than 40 years, who fulfill the clinical criteria for possible, probable or definite FH should qualify for the FH mutation testing.

TL;DR: Familial hypercholesterolaemia is inadequately diagnosed and treated in Poland, which calls for a radical im-provement of pre- and postgraduate education in this regard.

TL;DR: The results of microcircula‐ tion measurements assessed simultaneously on the forearm during and following brachial ar‐ tery occlusion by LSCI and FMSF are presented, the first re‐ port on a complex noninvasive assessment of mi‐ crocirculation in a patient with FH.

TL;DR: In this paper, microvascular endothelial function was assessed in familial hypercholesterolemia (FH) patients and healthy controls using flow mediated skin fluorescence (FMSF), based on measurements of nicotinamide adenine dinucleotide fluorescence intensity during brachial artery occlusion (ischemic response, IR).

TL;DR: Cholesterol, and no other risk factors, is a key contributor to cardiovascular risk in patients with FH, especially those with genetic mutation, according to a study comparing cardiovascular risk factors in a cohort of FH patients to the representative sample of adults in Poland.